glp-1 receptor agonists adverse effects of GI Adverse Effects of Glucagon-Like

Clinical utility of cardiovascular risk scores for identification of people with type 2 diabetes more likely to benefit from either GLP-1 receptor agonist or SGLT2 inhibitor therapy

12-14 Exenatide is available in pen form, potentially making dosing and administration more convenient ( TABLE 1 )

In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)

Pederson, R

Caregivers also reported decreased appetite and less impulsive eating behavior [22]

Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss, Mohit Sodhi, MSc, a fourth-year medical student at the University of British Columbia, said in a related press release